Genetic engineering may hold key to Lyme disease vaccine

04/6/2010 | USA Today

Researchers found that deactivating one gene in the tick-borne bacteria that cause Lyme disease helped prevent mice from contracting the disease. The hope is that the research by Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention in Fort Collins, Colo., holds the key to a human vaccine.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX